Indication: Medulloblastoma

NEWLY DIAGNOSED CHILDREN (LESS THAN 10 YEARS OLD) WITH MEDULLOBLASTOMA AND OTHER CENTRAL NERVOUS SYSTEM EMBRYONAL TUMORS: CLINICAL AND MOLECULAR RISK-TAILORED INTENSIVE AND COMPRESSED INDUCTION CHEMOTHERAPY FOLLOWED BY CONSOLIDATION WITH EITHER SINGLE CYC

Sub-indication: Medulloblastoma

Drug Study

Principal Investigator: Michael Huang, M.D.
Norton Children's Cancer Institute, affiliated with the UofL School of Medicine

Sponsor: Nationwide Children's Hospital

Search our entire site.